Self-Administered Etripamil Safe, Effective for Paroxysmal Supraventricular Tachycardia

FRIDAY, Sept. 29, 2023 (HealthDay News) -- Investigational etripamil nasal spray is well tolerated for self-treating recurrent episodes of paroxysmal supraventricular tachycardia (PSVT) without medical supervision, according to a study published online Sept. 27 in the Journal of the American Heart Association.
James E. Ip, M.D., from Weill Cornell Medicine and the NewYork-Presbyterian Hospital in New York City, and colleagues conducted an open-label extension of the phase 3 NODE-301 to assess the safety and efficacy of the L‐type calcium channel blocker etripamil. The analysis included 105 patients who were monitored via a self-applied cardiac monitoring system for five hours after etripamil self-administration for PSVT.
The researchers found that during a median 232 days of follow-up, the probability of conversion within 30 minutes of etripamil was 60.2 percent (median time to conversion, 15.5 minutes) among 188 PSVT episodes (92 patients) positively adjudicated as atrioventricular nodal-dependent by independent electrocardiogram analysis. Forty patients self-treated two PSVT episodes, and among these participants, three-quarters had a significantly consistent response by 30 minutes, nine did not convert on either episode, and 21 converted on both episodes. Treatment-emergent adverse events occurred in 42.9 percent of patients, which were generally transient and mild-to-moderate (e.g., nasal congestion [14.3 percent], nasal discomfort [14.3 percent], or rhinorrhea [12.4 percent]). Within 24 hours of etripamil self-administration, no serious cardiac safety events were seen.
"This is a potential new and exciting option for patients to safely self-treat their rapid heartbeat without direct medical supervision to avoid emergency room visits and medical interventions," Ip said in a statement.
Several authors disclosed ties to pharmaceutical companies, including Milestone Pharmaceuticals, which manufactures etripamil and funded the study.
Related Posts
Infertility Risk Perception Increased in Survivors of Adolescent and Young Adult Cancer
FRIDAY, Oct. 13, 2023 (HealthDay News) -- Survivors of adolescent and young...
¿Moderna o Pfizer? Una de las vacunas contra la COVID quizá sea más segura para los adultos mayores
JUEVES, 3 de agosto de 2023 (HealthDay News) -- Aunque se considera que las...
Las entregas de alcohol a domicilio aumentaron en la pandemia, con efectos permanentes para la salud
MIÉRCOLES, 28 de junio de 2023 (HealthDay News) -- Durante la pandemia de...
CDC: U.S. Cases of Acute Hepatitis in Children Keep Rising
THURSDAY, May 19, 2022 (HealthDay News) -- The number of American children...